Such changes include DNA methylation alterations occurring in tumour tissue compared with normal breast tissue as well as DNA methylation differences by key clinical variables such as hormonal receptor status, tumour stage, treatment modality or age at diagnosis [4–7]. Here, NR4A1 is linked to neoplasm.